Detalles de la búsqueda
1.
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
Clin Gastroenterol Hepatol
; 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492904
2.
Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients with a HIstoRy of CancEr: SAPPHIRE Registry.
Clin Gastroenterol Hepatol
; 2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768673
3.
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Am J Gastroenterol
; 118(2): 317-328, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36191274
4.
The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.
J Clin Gastroenterol
; 2023 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37646564
5.
Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.
J Gastroenterol Hepatol
; 38(2): 241-250, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36258306
6.
Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination.
Clin Gastroenterol Hepatol
; 20(6): e1493-e1499, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34896283
7.
Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 20(3): e361-e379, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33798711
8.
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability.
Clin Gastroenterol Hepatol
; 20(4): e761-e769, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34033922
9.
Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.
Gastroenterology
; 161(1): 211-224, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33741315
10.
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 126-135, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33039584
11.
Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.
Am J Gastroenterol
; 117(8): 1288-1295, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416799
12.
A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease.
J Clin Gastroenterol
; 56(3): e176-e182, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35180182
13.
Article Topic: Positioning Ulcerative Colitis Therapies in 2022 and Beyond.
Curr Gastroenterol Rep
; 24(12): 157-170, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327029
14.
Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimics.
Bioorg Chem
; 109: 104661, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33636438
15.
Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.
Dig Dis Sci
; 66(6): 2005-2013, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32617771
16.
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(13): 2952-2961.e8, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062041
17.
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 17(8): 1533-1540.e2, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268561
18.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(12): 2497-2505.e1, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625408
19.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
Gastroenterology
; 155(3): 687-695.e10, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29857091
20.
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Am J Gastroenterol
; 113(12): 696, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30390030